Halozyme Therapeutics (HALO) EBIT Margin (QoQ) (2010 - 2026)
Halozyme Therapeutics (HALO) EBIT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,954.00 |
| Dec 31, 2025 | -8,208.00 |
| Sep 30, 2025 | -64.00 |
| Jun 30, 2025 | 871.00 |
| Mar 31, 2025 | -545.00 |
| Dec 31, 2024 | 263.00 |
| Sep 30, 2024 | 558.00 |
| Jun 30, 2024 | 190.00 |
| Mar 31, 2024 | 486.00 |
| Dec 31, 2023 | 306.00 |
| Sep 30, 2023 | -187.00 |
| Jun 30, 2023 | 955.00 |
| Mar 31, 2023 | -787.00 |
| Dec 31, 2022 | 120.00 |
| Sep 30, 2022 | 1,750.00 |
| Jun 30, 2022 | -4,217.00 |
| Mar 31, 2022 | 910.00 |
| Dec 31, 2021 | -983.00 |
| Sep 30, 2021 | -293.00 |
| Jun 30, 2021 | 1,120.00 |